(Q54415396)

29 May 2018

title

A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic. (English)

1 reference

29 May 2018

1 reference

D S Hoon

1

1 reference

29 May 2018

I A Ramshaw

series ordinal

2

1 reference

29 May 2018

publication date

1 January 1987

1 reference

29 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

29 May 2018

volume

24

1 reference

29 May 2018

issue

1

1 reference

29 May 2018

page(s)

42-48

1 reference

29 May 2018

Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells

cites work

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

1 reference

12 December 2020

Suppressor Cells: Permitters and Promoters of Malignancy?

1 reference

12 December 2020

Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.

1 reference

12 December 2020

Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency

1 reference

12 December 2020

Macrophages suppress CTL generation in rat mixed leukocyte cultures

1 reference

12 December 2020

The lymphocyte surface. II. Separation of Fc receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes

1 reference

12 December 2020

Abrogation of thein vitro generation of the cytotoxic T-cell response to a murine tumor: The role of suppressor cells

1 reference

12 December 2020

Membrane-associated alterations detected in poorly tumorigenic lectin-resistant variant sublines of a highly malignant and metastatic murine tumor.

1 reference

12 December 2020

Regulation of the immune response II. Repressor T cells in cyclophosphamide-induced tolerant mice

1 reference

12 December 2020

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line

1 reference

12 December 2020

Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma

1 reference

12 December 2020

In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide

1 reference

12 December 2020

A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic.

1 reference

12 December 2020

Analysis of mammary tumour cell metastasis and release of bound n-acetylneuraminic acid

1 reference

12 December 2020

Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway

1 reference

12 December 2020

Heritable alterations in tumor-cell immunogenicity

1 reference

12 December 2020

Antigenic Tumor Cell Variants Obtained with Mutagens

1 reference

12 December 2020

Acquisition of paralytic activity by inducer cells

1 reference

12 December 2020

Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor

1 reference

12 December 2020

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1 reference

12 December 2020

Circulating immune complexes and immunoglobulin M-class rheumatoid factor in rats bearing mammary adenocarcinomas which vary in ability to metastasize

1 reference

12 December 2020

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

12 December 2020

Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199831

1 reference

29 May 2018

1 reference

29 May 2018